{
  "ticker": "JNJ",
  "target_date": "2025-03-13",
  "actual_date": "2025-03-13",
  "collected_at": "2025-12-08T11:30:47.956192",
  "price": {
    "open": 159.85,
    "high": 160.93,
    "low": 159.09,
    "close": 159.4148712158203,
    "volume": 5286700,
    "change_1d_pct": 0.09,
    "change_7d_pct": -1.47,
    "change_30d_pct": 8.7
  },
  "technicals": {
    "rsi_14": 51.66,
    "sma_20": 159.29,
    "sma_50": 150.23,
    "macd": 3.203,
    "macd_signal": 3.823,
    "macd_histogram": -0.62,
    "bb_upper": 167.2,
    "bb_lower": 151.37,
    "price_vs_sma20_pct": 0.08,
    "price_vs_sma50_pct": 6.12,
    "volume_ratio": 0.54
  },
  "fundamentals": {
    "market_cap": 489038708736,
    "pe_ratio": 19.592665,
    "forward_pe": 19.149055,
    "price_to_book": 6.160804,
    "price_to_sales": 5.307043,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.32,
    "pct_from_52w_low": 44.28
  },
  "macro": {
    "spy": {
      "price": 546.63,
      "change_1d_pct": -1.33,
      "change_7d_pct": -5.43
    },
    "vix": {
      "level": 24.66,
      "signal": "ELEVATED"
    },
    "treasury_10y": {
      "yield_pct": 4.27
    },
    "dollar_index": {
      "level": 103.83
    },
    "gold": {
      "price": 2984.3
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "Johnson & Johnson (NYSE:JNJ) Faces Shareholder Activism Over Human Rights and Executive Pay Proposals",
      "source": "Yahoo",
      "datetime": 1741886924,
      "summary": "Johnson & Johnson (NYSE:JNJ) is currently addressing shareholder proposals regarding executive compensation and human rights assessments, with recommendations to vote against them at its annual meeting on April 24, 2025. This may have contributed to the company's recent 11% price increase over the l",
      "url": "https://finnhub.io/api/news?id=516c08431f7852d5bbd7c5636f4e263b28ee3916285d45e970773ed3bb8ff7c0"
    },
    {
      "headline": "FDA grants 510(k) clearance for J&J MedTech\u2019s Monarch Quest",
      "source": "Yahoo",
      "datetime": 1741860994,
      "summary": "Monarch Quest provides physicians with a continuous vision.",
      "url": "https://finnhub.io/api/news?id=7fe0f2af791572220f0d6f81409a0b9d2b74e36a3a2fc9f335b4c3595bce9106"
    },
    {
      "headline": "J&J\u2019s Monarch robot wins FDA nod for AI software update",
      "source": "Yahoo",
      "datetime": 1741860000,
      "summary": "Using Nvidia and GE Healthcare technology, the robotic surgery system is intended to help doctors\u00a0detect\u00a0lung cancer earlier.",
      "url": "https://finnhub.io/api/news?id=206b087a7d534311e630d6e36434dbdff0c85933b0eec4337fa78ae718367685"
    },
    {
      "headline": "Why Johnson & Johnson (JNJ) is the Best Pharma Stock to Buy According to Hedge Funds",
      "source": "Yahoo",
      "datetime": 1741804014,
      "summary": "We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other best pharma stocks to buy according to hedge funds. Why is China the Talk of the Town in [\u2026]",
      "url": "https://finnhub.io/api/news?id=69a67d28f25787a36e848fa3c19962a31e24e6f183b1db9fd845cb5dc5a43eca"
    },
    {
      "headline": "Johnson & Johnson : 2025 Proxy Statement and additional solicitation materials (Johnson Johnson 2025 Proxy)",
      "source": "Finnhub",
      "datetime": 1741788012,
      "summary": "2025 Proxy Statement and Additional Definitive Proxy Solicitation Materials Definitive Proxy Statement, filed March 12, 2025 ...",
      "url": "https://finnhub.io/api/news?id=b1959e33189e69f08c2ecb71e923f3d09fd8dd831197c0e8c5302001cc3bca42"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-03-06",
      "description": "xslF345X05/wk-form4_1741297319.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000095/xslF345X05/wk-form4_1741297319.xml"
    },
    {
      "form": "4",
      "date": "2025-03-06",
      "description": "xslF345X05/wk-form4_1741297124.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000093/xslF345X05/wk-form4_1741297124.xml"
    },
    {
      "form": "4",
      "date": "2025-02-26",
      "description": "xslF345X05/wk-form4_1740613359.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000086/xslF345X05/wk-form4_1740613359.xml"
    },
    {
      "form": "8-K",
      "date": "2025-02-26",
      "description": "d863514d8k.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000119312525036773/d863514d8k.htm"
    },
    {
      "form": "8-K",
      "date": "2025-02-20",
      "description": "d866332d8k.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000119312525030851/d866332d8k.htm"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}